Life sciences company Hikal has opened a High Potency Active Pharmaceutical Ingredient (HPAPI) laboratory at its Research and Technology Innovation Centre in Pune.

This new facility enhances Hikal’s Contract Development and Manufacturing Organisation (CDMO) capabilities, enabling the company to develop and supply highly potent compounds for the global pharmaceutical industry. The lab is specifically designed to support the development of complex oncology and specialty molecules. According to Sameer Hiremath, vice chairman and managing director of Hikal, this addition positions the company well to meet the increasing demand for potent molecule development.

This addition positions the company well to meet the increasing demand for potent molecule development, said Sameer Hiremath, vice c

See Full Page